Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Rumors About XRP Circulating Regarding a Major Company Listed on Nasdaq

Rumors About XRP Circulating Regarding a Major Company Listed on Nasdaq

CryptoNewsNetCryptoNewsNet2025/10/08 19:06
By:en.bitcoinsistemi.com

Nasdaq-listed Reliance Global Group announced that it has added XRP to its treasury, expanding its digital asset portfolio.

In a filing with the U.S. Securities and Exchange Commission (SEC), the company confirmed its purchase of XRP, along with Bitcoin, Ethereum, and Cardano. The XRP investment is reportedly worth approximately $17 million.

The company described the addition of XRP as a “strategic step towards digital assets with strong fundamentals and real-world use cases.”

Analysts say Reliance's investments in XRP and other cryptocurrencies could indicate the company could be working on tokenized insurance policies or XRPL (XRP Ledger)-based payment integrations in the future. Similar initiatives have previously been announced by companies in the pharmaceutical and travel sectors.

In its statement, Reliance argued that its digital asset strategy is driven by the goal of creating innovation, stability, and shareholder value over the long term. XRP's advantages, such as low transaction costs, speed, and energy efficiency, were cited as key factors supporting the company's corporate digital finance strategy.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose

This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.

华尔街见闻•2026/09/29 00:26

AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs

AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.

智通财经•2026/09/29 00:06